<DOC>
	<DOCNO>NCT00281060</DOCNO>
	<brief_summary>Minimal invasive treatment ( call `` endovascular '' ) arteries low limb remain problematic , recurrent disease ( `` restenosis '' ) frequently lead recurrent symptom . As yet , balloon angioplasty remain recommended strategy revascularize superficial femoral artery ( artery thigh ) . We investigate whether use vascular endoprosthesis ( `` stent '' ) improve patients´ outcome . Study hypothesis : Primary stenting self expand nitinol stent may improve patency endovascular treatment superficial femoral artery obstruction compare balloon angioplasty optional stenting .</brief_summary>
	<brief_title>Vienna Absolute Trial : Balloon Angioplasty Versus Stenting Superficial Femoral Artery</brief_title>
	<detailed_description>STUDY DESIGN . From June 2003 August 2004 , screen consecutive patient refer endovascular treatment SFA due intermittent claudication chronic critical limb ischemia enrollment randomize single-institution trial . Patients potential candidate percutaneous intervention discuss twice weekly consensus meeting angiologist , vascular surgeon interventional radiologist prior consider trial enrollment . The protocol approve institutional ethic committee , patient provide write informed consent . The clinical criterion study entry symptomatic peripheral artery disease ( PAD ) either severe intermittent claudication ( Rutherford class 3 ) chronic critical limb ischemia rest pain ( Rutherford class 4 ) ischemic ulcer ( Rutherford class 5 ) 1 . Anatomic inclusion criterion , base upon finding biplane DSA time intervention , &gt; 50 % stenosis occlusion ipsilateral SFA target lesion length 30mm , least one patent ( &lt; 50 % stenosis ) tibio-peroneal run-off vessel . Exclusion criterion acute critical limb ischemia , previous bypass surgery stenting SFA , untreated inflow disease ipsilateral pelvic artery ( &gt; 50 % stenosis occlusion ) , know intolerance study medication contrast agent . STUDY END POINTS . The primary study end point binary rate restenosis treat segment within 6 month postintervention compute tomography angiography ( CTA ) digital subtraction angiography ( DSA ) . Restenosis define &gt; 50 % lumen diameter reduction bad angiographic view narrow site within limit treat segment plus adjacent ten millimeter proximal distal treat segment . Secondary end point 1. anatomic outcome parameter : binary restenosis &gt; 50 % duplex ultrasonography ( 3 , 6 12 month ) ; angiographic degree restenosis ( % diameter reduction 6 month ) ; occurrence stent fracture biplane X-ray ( 6 12 month ) ; 2. clinical outcome parameter : Rutherford stage PAD maximum walk capacity treadmill ( 24 hour , 3 , 6 12 month ) ; amputation death ( 12 month ) ; 3. hemodynamic outcome parameter : rest ankle brachial index ( ABI ) ( 24 hour , 3 , 6 12 month ) . Evaluation follow-up data adjudication primary secondary end point perform two independent blind observer . Discordances resolve consensus third blind investigator . INTERVENTIONS . Interventions perform percutaneously antegrade over-the-bifurcation approach use 6 French sheath . Biplane DSA perform use two view least 30° apart evaluate lesion morphology , inflow disease run-off . For precise documentation location lesion site intervention ruler fix patients´ thigh distal end exactly overlap upper edge patella . After successful wire passage target lesion , patient randomly assign either primary stent implantation PTA optional secondary stenting , use computer generate random digit randomization block four seal envelope . Stratification criterion claudication versus critical limb ischemia , length target lesion ( ≤ versus &gt; 60 mm ) . In stent group , primary stenting without predilation perform except patient tight stenosis heavily calcify lesion allow primary passage stent introducer device . Stents implant extend 10 mm proximal distal margin target lesion . When multiple stent require , margin stent overlap 10 mm . Postdilation stenting perform strictly within stented segment 10 % oversizing post-dilation balloon . In PTA group minimal time balloon inflation 2 minute 10 12 atmosphere . After dilation entire target segment , biplane control angiogram obtain . In case suboptimal primary result , define residual stenosis &gt; 30 % presence flow limit dissection bad angiographic view , second prolong balloon dilation ( &gt; 2 minute ) target segment perform . In patient persistent suboptimal result second balloon dilation , secondary stenting perform . For stent implantation group , self-expandable nitinol stent ( Dynalink / Absolute , Guidant , Santa Clara , CA ) nominal diameter 6 mm use . Biplane angiogram perform intervention treatment group , use angle magnification baseline angiogram . MEDICAL THERAPY . All patient receive aspirin 100mg daily indefinitely clopidogrel 75 mg daily 3 month postintervention . Aspirin clopidogrel initiate least 2 day prior intervention patient ; otherwise load dose 300 mg clopidogrel give intervention . SURVEILLANCE PROTOCOL . Examinations perform baseline 24 hour , 3 month , 6 month 12 month randomization , include stag PAD Rutherford1 , measurement rest ABI , treadmill exercise testing ( 3.2 km/h 12° slope ) , color duplex ultrasonography16 . At 6 12 month X-rays two plane obtain evaluation stent fracture . Angiographic evaluation restenosis 6 month perform use either 16 slice CTA conventional intra-arterial DSA . CTAs perform `` Somatom Sensation 16 '' 16-row , multi-slice CT scanner ( Siemens Medical Systems , Erlangen , Germany ) . The accuracy specificity multi-slice CT automate reconstruction report comparable intra-arterial DSA17-20 . All patient suspect restenosis ( &gt; 50 % ) CTA underwent conventional DSA confirmation diagnosis . We perform DSA rather CTA initial imaging procedure patient plan ipsilateral contralateral ( ) intervention 6-month follow-up visit . STATISTICAL METHODS AND SAMPLE SIZE CALCULATION . A sample size 100 110 patient estimate necessary assume 6-month restenosis rate 50 % PTA group3 25 % nitinol stent group11 . A two-sided p-value 0.05 consider statistically significant power 80 % require 10 % maximum drop-out rate . Data analysis primary secondary study end point perform accord intention-to-treat principle . A secondary as-treated ( per-protocol ) analysis compare result stent implantation ( primary secondary ) vs. PTA alone respect primary study end point . Descriptive data give mean ± SD , , non-normal distribution censor data set , median interquartile range ( range 25th 75th percentile ) , analyze Mann Whitney U test . Proportions compare Chi square statistic Yates ’ correction exact test , appropriate . Kappa statistics 95 % confidence interval use assess agreement angiography duplex ultrasound . Multivariable logistic regression analysis apply assess association treatment restenosis adjust potentially confounding factor . We convert odds ratio derive multivariate model risk ratio ( RR ) 95 % confidence interval ( CI ) . Multiplicative interaction term log likelihood ratio test use test interaction . Calculations perform use Stata release 8.0 ( Stata Inc. College Station , TX , U.S. ) .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Symptomatic peripheral artery disease Rutherford stag 3 5 &gt; 50 % stenosis ipsilateral superficial femoral artery Lesion length &gt; 30mm At least one patent crural runoff vessel , Acute criticla limb ischemia Previous ipsilateral bypass surgery ipsilateral SFA stenting Untreated inflow disease Known intolerance clopidogrel , aspirin radiocontrast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>endovascular</keyword>
	<keyword>balloon angioplasty</keyword>
	<keyword>stent</keyword>
</DOC>